Blueprint Medicines (BPMC) Given “Outperform” Rating at Wedbush Fairfield Current
Wedbush restated their outperform rating on shares of Blueprint Medicines (NASDAQ:BPMC) in a research report report published on Monday, January 7th.
Blueprint Medicines (BPMC) Given “Outperform” Rating at Wedbush Fairfield Current
Wedbush restated their outperform rating on shares of Blueprint Medicines (NASDAQ:BPMC) in a research report report published on Monday, January 7th.
